NEW YORK (Reuters Health) - For people with a history of colorectal polyps or cancer, taking aspirin is an effective way to reduce the chances of new polyps appearing, according to researchers in ...

The National Cancer Institute predicts that colorectal cancers will make up 8% of new cancer cases in 2025, and it is often recurring, so scientists are looking for ways to reduce the risk of it ...

Singapore, 17 March 2025 – A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led by Singapore ...

Doctors have long recommended daily aspirin for years as a low-cost protection against cancers of the lower bowel.

Aspirin is often touted as the wonder drug of the 20th century. Famous for its versatility—easing aches and pains, reducing fever and inflammation, preventing heart attacks and stroke—experts have ...

Two aspirin a day can reduce the risk of colorectal cancer by more than 60 percent, according to a study published in The Lancet medical journal. The study, which spanned more than a decade, found ...

Colorectal, or bowel, cancer is the third most common cancer worldwide. According to the World Health Organization (WHO), in 2022 alone there were 1.9 million new cases of colorectal cancer and it ...

Aspirin may reduce the likelihood of recurrent polyps. * THE QUESTION Does aspirin affect the risk of recurrent polyps? * PAST STUDIES have shown that people who take aspirin or other nonsteroidal ...